Publications by authors named "Matteo Da-Via"

Claim this Profile
G
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, Shaji Kumar, Kylee Maclachlan

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment.
Nicolas A Gort-Freitas, Maria Moscvin, Matteo C Da Vià, Francesca Lazzaroni, Alice Nevone

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing.
Bruno Fattizzo, Matteo Claudio Da Vià, Francesca Lazzaroni, Alfredo Marchetti, Alessio Marella

Signal Transduct Target Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes.
Marta Lionetti, Margherita Scopetti, Antonio Matera, Akihiro Maeda, Alessio Marella

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma.
Matteo Claudio Da Vià, Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis.
Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Giancarlo Castellano

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TENT5C/FAM46C modulation reveals a trade-off between antibody secretion and tumor growth in multiple myeloma.
Massimo Resnati, Sara Pennacchio, Lisa Viviani, Tommaso Perini, Maria Materozzi

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma.
Filippo Bagnoli, Giuditta Pini, Bachisio Ziccheddu, Arturo Bonometti, Silvia Alberti-Violetti

Clin Exp Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell-redirecting therapy.
Johannes Duell, Alexander M Leipold, Silke Appenzeller, Viktoria Fuhr, Hilka Rauert-Wunderlich

Blood· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory cytokines and clonal dynamics in low-risk myelodysplastic syndromes patients treated with luspatercept.
Bruno Fattizzo, Alfredo Marchetti, Anna Zaninoni, Marta Lionetti, Marta Riva

Am J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients.
Loredana Pettine, Marta Bortolotti, Bruno Fattizzo, Matteo C Da Vià, Dario Consonni

Hematol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma.
Larissa Haertle, Santiago Barrio, Umair Munawar, Seungbin Han, Xiang Zhou

Clin Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.
Cirino Botta, Emilia Gigliotta, Bruno Paiva, Rita Anselmo, Marco Santoro

Hematol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma.
Antonio Matera, Alessio Marella, Akihiro Maeda, Matteo C Da Vià, Francesca Lazzaroni

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort.
Matteo Claudio Da Vià, Marta Lionetti, Alessio Marella, Antonio Matera, Erica Travaglino

Blood Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualizing the Interactions Shaping the Imaging of the Microenvironment in Human Cancers.
Antonio G Solimando, Vanessa Desantis, Matteo Claudio Da Vià

Methods Mol Biol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring "Multiple Myelomas".
Antonio Giovanni Solimando, Matteo Claudio Da Vià, Niccolò Bolli, Torsten Steinbrunn

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients.
Bruno Fattizzo, Marta Bortolotti, Nicolò Rampi, Francesca Cavallaro, Juri Alessandro Giannotta

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Immunologic Mechanisms of Myeloid Neoplasms.
Bruno Fattizzo, Matteo Claudio Da Vià, Austin G Kulasekararaj

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans.
Andreas Brandl, Antonio G Solimando, Zeinab Mokhtari, Paula Tabares, Juliane Medler

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma.
Bachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, Akihiro Maeda, Silvia Morlupi

Clin Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single- and double-hit events in genes encoding immune targets before and after T cell-engaging antibody therapy in MM.
Marietta S Truger, Johannes Duell, Xiang Zhou, Larissa Heimeshoff, Anna Ruckdeschel

Blood Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment.
Giada Bianchi, Peter G Czarnecki, Matthew Ho, Aldo M Roccaro, Antonio Sacco

Blood Cancer Discov· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
Marta Lionetti, Matteo C Da Vià, Francesco Albano, Antonino Neri, Niccolò Bolli

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia.
Andoni Garitano-Trojaola, Ana Sancho, Ralph Götz, Patrick Eiring, Susanne Walz

Commun Biol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis